Ifp Advisors, Inc Chembio Diagnostics, Inc. Transaction History

Ifp Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.45 - $0.8 $168 - $300	375 New	375 $4,000
Q2 2022 Aug 12, 2022	SELL	$0.45 - $0.8 $168 - $300	-375 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$3.18 - $15.54 $795 - $3,885	-250 Reduced 40.0%	375 $1,000
Q3 2019 Nov 07, 2019	BUY	$4.84 - $7.25 $3,025 - $4,531	625 New	625 $4,000
Q1 2019 May 15, 2019	SELL	$5.32 - $7.18 $1,995 - $2,692	-375 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$4.95 - $10.5 $1,856 - $3,937	375 New	375 $2,000
Q4 2017 Jan 24, 2018	SELL	$5.95 - $8.35 $3,718 - $5,218	-625 Closed	0 $0
Q1 2017 Jun 03, 2019	BUY	N/A	375 Added 150.0%	625 $3,000
Q4 2016 Jun 03, 2019	BUY	N/A	250	250 $2,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.